Testimony Struck From Vioxx Trial

Staff Writer

Contributor

0 CommentsPrint ArticleSubscribe

Vioxx was pulled from the market after the arthritis drug was linked to heart attacks, strokes and blood clots. The second Vioxx trial is currently taking place in Atlantic City, New Jersey, where Superior Court Judge Carol Higbee struck the testimony of a Merck researcher (the defense’s first witness).

Vioxx was pulled from the market after the arthritis drug was linked to heart attacks, strokes and blood clots. The second Vioxx trial is currently taking place in Atlantic City, New Jersey, where Superior Court Judge Carol Higbee struck the testimony of a Merck researcher (the defense's first witness). Judge Higbee said she felt sickened and misled by the testimony of Dr. Briggs Morrison. USA Today documents the courtroom action.

Bextra and Celebrex are in the same class of arthritis drugs (Cox-2 inhibitors) as Vioxx.